ofa lawsuit tirzepatide Eli Lilly sues companies selling alternative versions of its weight loss drug Lilly seeks to intervene in

Tirzepatide is a dual GLP-1 and GIP receptor agonist, while semaglutide is a GLP-1 receptor agonist only

From allergic reactions to more severe conditions like mycotoxicosis, molds effects are diverse

Strength Train 34 Times Per Week Focus on compound movements like squats, deadlifts, overhead presses, and rows

I dont want to give patients something that hasnt been proven or studied significantly. Other experts go further

Research in people with diabetes has found that those treated with GLP-1 receptor agonists were almost twice as likely to test positive for SIBO compared with people treated with other diabetes medications